Work

Results of a Phase 1 Dose-Ranging Trial, and Design of a Phase 2 Trial, of K0706, a Novel C-Abl Tyrosine Kinase Inhibitor for Parkinson’s Disease. (P2.8-047)

Year: 2019

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.92.15_supplement.p2.8-047

Authors: Andrew Goldfine, Robert Faulkner, Vasu Sadashivam, Omid Omidvar, John Hill, Singaravelu Jagadeesan, Anil Sharma, Siu-Long Yao

Institutions: Avail Clinical Research, Wake Research

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2969478339

FWCI: 1.167

Cites:

Cited by: 11

Related to: 10